FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

787869008: Product containing only dapagliflozin and metformin and saxagliptin (medicinal product)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3777347010 Product containing only dapagliflozin and metformin and saxagliptin (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3777348017 Dapagliflozin and metformin and saxagliptin only product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3777347010 Product containing only dapagliflozin and metformin and saxagliptin (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3777348017 Dapagliflozin and metformin and saxagliptin only product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dapagliflozin and metformin and saxagliptin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dapagliflozin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 3
Dapagliflozin and metformin and saxagliptin only product Is a Dapagliflozin- and metformin- and saxagliptin-containing product true Inferred relationship Existential restriction modifier (core metadata concept)
Dapagliflozin and metformin and saxagliptin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Metformin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Dapagliflozin and metformin and saxagliptin only product Count of base of active ingredient trois false Inferred relationship Existential restriction modifier (core metadata concept)
Dapagliflozin and metformin and saxagliptin only product Plays role Antidiabetic therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Dapagliflozin and metformin and saxagliptin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Saxagliptin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only dapagliflozin and metformin and saxagliptin in oral dose form (medicinal product form) Is a True Dapagliflozin and metformin and saxagliptin only product Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start